.svg){kind=small}
Oct-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Is this your brand?
See your full sales and distribution data: where you sell, how you're priced, and how you rank against the brands next to you on the shelf.
See your brand's dataCarry this brand in your store?
Headset Retailer is free. Connect your POS and see what's selling and what's sitting.
Sign up freeWhere to Buy
High Falls Canna New York is stocked at 75 licensed dispensaries across New York, with the deepest coverage in New York, Brooklyn, Queens, Staten Island, and Albany. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
High Falls Canna New York’s mix in New York in October 2026 was led by Flower at 43.06% share (YoY -43.86%, MoM -21.89%), while Pre-Roll expanded to 33.86% share with YoY +48.15% and MoM +5.12%. Tincture & Sublingual held 12.04% share with YoY -48.21% and MoM -4.52%, and Concentrates rose to 9.90% share on a YoY +211.91% despite MoM -13.81%; Edible shrank to 0.51% share with YoY -92.50% and MoM -12.53%. Combined with an average price decline of 35.94% YoY and brand-level sales down 25.25% YoY, the shift toward Pre-Roll and Concentrates amid Flower contraction implies a demand reallocation toward lower-ticket inhalables and potency-forward formats at the expense of legacy tincture and edible lines.
The pattern suggests a portfolio repositioning opportunity: with Flower’s contraction outpacing the brand’s overall -25.25% YoY, increasing Pre-Roll’s +48.15% YoY and Concentrates’ +211.91% YoY momentum could offset volatility, while stabilizing MoM declines in Flower (-21.89%) and Concentrates (-13.81%) would reduce mix risk. Given a current Flower rank of 82 in New York and Pre-Roll’s MoM +5.12% alongside a category price point near $9.09 versus Flower at $35.02, the mix points to price-sensitive acquisition via Pre-Roll complemented by potency-led trade-up in Concentrates, implying the brand’s near-term positioning leans on entry-price inhalables to rebuild velocity while trimming exposure to low-traction Edible (0.51% share) and declining Tincture & Sublingual (-4.52% MoM).
Competitive Landscape
High Falls Canna New York sits at rank #82 in October 2026, down 30 positions year over year from #52, and 28 spots below its July 2026 mark of #54, while still far from its peak rank of #32 in February 2025; meanwhile, competitor Leal moved from #2 to #1 with 31.5% YoY sales growth and Find. advanced from #5 to #2 alongside 36.2% YoY sales growth, indicating that leaders are consolidating share as High Falls Canna New York slides. With RYTHM climbing from #7 to #3 and Grassroots rising from #14 to #5 on 112.3% YoY sales growth, High Falls Canna New York’s two-step decline from July 2026 to October 2026 and thirty-place YoY drop imply a trajectory where recovery will require countering faster-moving rivals’ momentum.
Notable Products
High Falls Canna New York prices well below comparable items in October 2026, with average list prices 17.7% under similar products, including Bliss Drops Tincture at 23.3% below and Sunset Sherbert (3.5g) at 26.6% below peers. This discounting spans multiple formats, so much of its sales come from value-priced Flower and Tincture alongside budget Pre-Rolls.
Peer avg: average price of the same product type and package size in the same states that month.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
